Investing51m
Consumer sentiment is improving, Morgan Stanley's survey shows
Investing.com -- Consumer sentiment in the U.S. hit a three-year high in October, according to Morgan Stanley’s latest AlphaWise survey, which tracked the spending intentions of U.S. consumers. The ...
Global equities were net bought last week: Goldman Sachs
Hedge funds “net sold US TMT stocks at the fastest pace in five weeks,” but Goldman Sachs noted that TMT stocks remained net ...
Strong European earnings have defied gloomy outlook in the region, BofA says
Investing.com - Strong earnings in Europe have defied a mostly gloomy outlook for the region, according to analysts at Bank ...
US CEOs fired more quickly over low stock prices this year, report says
U.S. companies with lagging stock prices are now quicker to blame management and fire their top executive, but the process of ...
Moldova's Sandu says she will press for change after narrow runoff win
Moldovan President Maia Sandu vowed to ring the changes after winning a runoff presidential ballot, an acknowledgement of the fragile foothold her pro-Western forces have ahead of key parliamentary ...
Bernstein downgrades Reckitt; litigation rollercoaster continues
Investing.com - Bernstein downgraded its investment stance on Reckitt Benckiser (LON: RKT), citing the continuation of a rollercoaster of litigation which has hit the consumer goo ...
Fiverr shares drop as BTIG cuts rating, removes from Top Pick list
Fiverr (NYSE: FVRR) shares were down 4% in pre-open trade on Monday after BTIG downgraded its rating on the stock to "neutral ...
Berkshire sells more Apple shares; stock falls
Apple shares declined roughly 0.6% in premarket trading on Monday after Berkshire Hathaway (NYSE: BRKa) revealed a ...
Peloton double-upgraded at BofA, 'many miles more of EBITDA growth likely'
Investing.com -- Bank of America double-upgraded Peloton (NASDAQ: PTON) to Buy from Underperform with a price target of $9, ...
ESSA Pharma downgraded by Oppenheimer, Piper Sandler after drug setback in trials
Such findings raised questions about the added benefit of masofaniten, leading ESSA to abandon the drug’s development. In light of these results, Piper Sandler removed any projected value for ...
Trump and Harris campaigns race to get the vote out on eve of US election
RALEIGH, North Carolina/DETROIT (Reuters) - A presidential election unlike any other in U.S. history enters its last full day on Monday with Donald Trump, Kamala Harris and their campaigns scrambling ...
Zoetis lifts full-year guidance amid strength at companion animal unit
Shares in Zoetis (NYSE: ZTS) edged higher in premarket US trading on Monday after the drugmaker reported better-than-anticipated third-quarter earnings and revenu ...